Home » 2019 » November

Biotech Stock Spikes On Promising First In-Human CRISPR Gene-Editing Drug

Shares of Crispr Therapeutics (CRSP) jumped Tuesday after the biotech company’s gene-editing approach showed early promise. During the regular session on the stock market today, Crispr stock popped 17%, to 68.46, in above-average volume. At nine months following infusion, the beta thalassemia patient didn’t need a blood transfusion. Four months after...
Read More